SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-023686
Filing Date
2021-02-01
Accepted
2021-02-01 07:21:52
Documents
5
Period of Report
2021-01-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d119419d8k.htm 8-K 40282
2 EX-2.1 d119419dex21.htm EX-2.1 561603
3 EX-10.1 d119419dex101.htm EX-10.1 73925
4 EX-99.1 d119419dex991.htm EX-99.1 50525
5 GRAPHIC g57202dsp001.jpg GRAPHIC 4255
  Complete submission text file 0001193125-21-023686.txt   733617
Mailing Address 1 MEDIMMUNE WAY GAITHERSBURG MD 20878
Business Address 1 MEDIMMUNE WAY GAITHERSBURG MD 20878 240-558-0038
Viela Bio, Inc. (Filer) CIK: 0001734517 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39067 | Film No.: 21574341
SIC: 2834 Pharmaceutical Preparations